How Sponsors Can Reduce Chaos at Study Sites During Decentralized Trials

Welcome to our comprehensive guide on managing the risks of decentralized clinical trials (DCTs). With 89% of research sponsors currently using and expecting to continue the use of decentralized technologies and methods in at least some of their studies, it’s clear that DCTs are an interesting innovation.

While DCTs offer numerous benefits, such as making clinical trials more accessible to participants and allowing trials to reach new patient populations, there are also challenges to consider. For example, the decentralization of clinical trials can create chaos at clinical trial sites, especially for sites managing complex trials.

In this guide, we’ll explore the key takeaways that sponsors must know to manage the risks of clinical trial sites moving to DCTs. Drawing on insights from more than 10,000 investigators in 44 countries, we’ll provide valuable information on how sponsors can reduce chaos at study sites during DCTs.

Our guide covers everything you need to know to ensure that disruptions in technology don’t lead to disruptions in outcomes. From understanding the challenges of managing DCTs at clinical trial sites to identifying the technology and training infrastructure needed to support DCTs, our guide is your go-to resource.

Whether you’re a research sponsor, investigator, or clinical trial site, this guide is essential reading. Don’t miss out on this valuable resource for managing the risks of decentralized clinical trials.